Business Model in Practice: Service Model

Tuesday, 25 June 2024, 12:00 – 12:45 


Giel Hendriks | CEO, Toxys

Giel Hendriks is the founder and CEO of Toxys. As CEO of Toxys, he worked to develop the company into an internationally recognized contract research organization (CRO) in chemical safety testing for industry. He has developed various in vitro assays to ensure the safety of novel medicines, chemicals and consumer products without the use of animals. He is an expert in genetic toxicology and has been co-chairing various expert working groups at the HESI GTTC and is the current president of the Dutch Environmental Mutagen Society. Giel has a PhD in molecular cell biology from Utrecht University and worked as a post-doctoral fellow in at Leiden University and Leiden University Medical Center.


Toxys

Toxys is a global leading expert that develops and offers a broad spectrum of unique animal-free laboratory tests for the safety assessment of novel medicines, chemicals, cosmetics and food. We are experts in the fields of genotoxicity, developmental toxicology and mechanistic toxicity testing. We develop assays with the focus on understanding the mode-of-action of toxic compounds. Our ToxTracker® assay accurately identifies genotoxic compounds, ReproTracker® detects developmental toxicity and the ToxProfiler™ assay provides a broad toxicity profile of compounds. Toxys is internationally recognised for its scientific expertise, high quality results and responsiveness. 

Powered by:
BCF Courses BV   

    Connect with us                  

Join BioBusiness Summer School

Privacy Policy
Terms & Conditions 

Chamber of Commerce: 75874415
         
  
  
  
                                    

        REGISTER NOW
    

© Copyright 2020 by BCF Courses